263409-81-0

Basic information

• Product Name: 2-(4-Fluorophenoxy)-1-ethanamine(HCl)
• Synonyms: 2-(4-Fluorophenoxy)-1-ethanamine(HCl)
• CAS NO: 263409-81-0
• Molecular Formula: C8H11ClFNO
• Molecular Weight: 191.63
• Mol File: 263409-81-0.mol
• Article Data: 5

Chemical Properties

• Melting Point: 213-216℃
• Boiling Point: 282.8oC at 760 mmHg
• Flash Point: 124.8oC
• Appearance: /
• Vapor Pressure: 0.00251mmHg at 25°C
• Storage Temp.: Inert atmosphere,Room Temperature
• Sensitive: Hygroscopic
• CAS DataBase Reference: 2-(4-Fluorophenoxy)-1-ethanamine(HCl)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-Fluorophenoxy)-1-ethanamine(HCl)(263409-81-0)
• EPA Substance Registry System: 2-(4-Fluorophenoxy)-1-ethanamine(HCl)(263409-81-0)

Safety Data

• Hazardous Substances Data: 263409-81-0(Hazardous Substances Data)

Usage

General Description

2-(4-Fluorophenoxy)-1-ethanamine(HCl) is a chemical compound that consists of a central ethanamine molecule with a fluorophenoxy group attached to it. The HCl in its name indicates that it is a hydrochloride salt. 2-(4-Fluorophenoxy)-1-ethanamine(HCl) may have applications in the pharmaceutical and chemical industries, as it can act as a building block for the synthesis of other organic compounds. It could also potentially be used in research and development of new drugs. However, it is important to note that this compound may have certain safety and handling considerations due to its potential chemical reactivity and health hazards, and it should be handled with care in a controlled laboratory setting.

InChI:InChI=1/C8H10FNO.ClH/c9-7-1-3-8(4-2-7)11-6-5-10;/h1-4H,5-6,10H2;1H

Upstream product

• 263409-78-5 tert-butyl (2-(4-fluorophenoxy)ethyl)carbamate 
• 24115-20-6 2-(4-fluorophenoxy)acetonitrile 
• 371-41-5 4-Fluorophenol 
• 332-48-9 2-(4-fluorophenoxy)-ethylbromide 

Relevant articles and documents

HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS

ABSTRACT The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

Development of a scalable synthesis of a nonbasic inhibitor of the serine protease tryptase

A chromatography-free process for the synthesis of a bis(benzimidazole)difluoromethane inhibitor of the serine protease tryptase is described. This synthesis features the introduction of the gem-difluoro moiety using the electrophilic fluorinating reagent N-fluoro-bis(phenylsulfonimide) as well as the stepwise introduction of both benzimidazole rings. A protocol for the destruction of reactive, process-related substances produced in the synthesis is also presented.

HYDROXY-TETRAHYDRO-NAPHTHALENYLUREA DERIVATIVES

This invention relates to hydroxy-tetrahydro-naphthalenylurea derivatives and salts thereof which are useful as active ingredients of pharmaceutical preparations. The hydroxy-tetrahydro-naphthalenylurea derivatives of the present invention have an excelle